Lynn Dorsey Bleil

Insider Reports History

Entity
Individual
Location
333 West 11 Th Street, Kansas City, MO
Signature
/s/ Stuart Funderburg, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lynn Dorsey Bleil:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AMICUS THERAPEUTICS, INC. Director Common Stock 93.5K $935K $10.00 Jun 6, 2024 Direct
STERICYCLE INC Director Common Stock 0 $0 $62.00 Nov 4, 2024 Direct
STERICYCLE INC Director Non-Qualified Stock Option (right to buy) 0 $0 $13.41 Nov 4, 2024 Direct
STERICYCLE INC Director Restricted Stock Units 0 $0 $62.00 Nov 4, 2024 Direct
AMICUS THERAPEUTICS, INC. Director Stock Options (right to buy) 42.5K Jun 6, 2024 Direct

Insider Reports Filed by Lynn Dorsey Bleil

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRCL STERICYCLE INC Nov 4, 2024 4 -$1.53M 4 Nov 4, 2024 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 6, 2024 2 $0 4 Jun 7, 2024 Director
SRCL STERICYCLE INC May 21, 2024 1 $0 4 May 23, 2024 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
SRCL STERICYCLE INC May 16, 2023 1 $0 4 May 17, 2023 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 9, 2022 2 $0 4 Jun 10, 2022 Director
SRCL STERICYCLE INC May 26, 2022 1 $0 4 May 27, 2022 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 10, 2021 2 $0 4 Jun 14, 2021 Director
SRCL STERICYCLE INC May 26, 2021 1 $0 4 May 27, 2021 Director
FOLD AMICUS THERAPEUTICS, INC. May 25, 2021 1 $250K 4 May 27, 2021 Director